Cologne Center for Genomics, University of Cologne, 50931 Cologne, Germany.
Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana, Universidad de Desarrollo, Santiago 7590943, Chile.
Brain. 2023 Mar 1;146(3):923-934. doi: 10.1093/brain/awac305.
Clinically identified genetic variants in ion channels can be benign or cause disease by increasing or decreasing the protein function. As a consequence, therapeutic decision-making is challenging without molecular testing of each variant. Our biophysical knowledge of ion-channel structures and function is just emerging, and it is currently not well understood which amino acid residues cause disease when mutated. We sought to systematically identify biological properties associated with variant pathogenicity across all major voltage and ligand-gated ion-channel families. We collected and curated 3049 pathogenic variants from hundreds of neurodevelopmental and other disorders and 12 546 population variants for 30 ion channel or channel subunits for which a high-quality protein structure was available. Using a wide range of bioinformatics approaches, we computed 163 structural features and tested them for pathogenic variant enrichment. We developed a novel 3D spatial distance scoring approach that enables comparisons of pathogenic and population variant distribution across protein structures. We discovered and independently replicated that several pore residue properties and proximity to the pore axis were most significantly enriched for pathogenic variants compared to population variants. Using our 3D scoring approach, we showed that the strongest pathogenic variant enrichment was observed for pore-lining residues and alpha-helix residues within 5Å distance from the pore axis centre and not involved in gating. Within the subset of residues located at the pore, the hydrophobicity of the pore was the feature most strongly associated with variant pathogenicity. We also found an association between the identified properties and both clinical phenotypes and functional in vitro assays for voltage-gated sodium channels (SCN1A, SCN2A, SCN8A) and N-methyl-D-aspartate receptor (GRIN1, GRIN2A, GRIN2B) encoding genes. In an independent expert-curated dataset of 1422 neurodevelopmental disorder pathogenic patient variants and 679 electrophysiological experiments, we show that pore axis distance is associated with seizure age of onset and cognitive performance as well as differential gain versus loss-of-channel function. In summary, we identified biological properties associated with ion-channel malfunction and show that these are correlated with in vitro functional readouts and clinical phenotypes in patients with neurodevelopmental disorders. Our results suggest that clinical decision support algorithms that predict variant pathogenicity and function are feasible in the future.
临床上鉴定出的离子通道遗传变异可能是良性的,也可能通过增加或减少蛋白质功能而导致疾病。因此,如果不对每个变异进行分子检测,治疗决策就具有挑战性。我们对离子通道结构和功能的生物物理知识才刚刚开始出现,目前还不太清楚哪些氨基酸残基发生突变会导致疾病。我们试图系统地识别所有主要电压门控和配体门控离子通道家族中与变异致病性相关的生物学特性。我们从数百种神经发育障碍和其他疾病中收集和整理了 3049 种致病性变异,以及 30 种离子通道或通道亚基的 12546 个人群变异,这些通道或通道亚基都有高质量的蛋白质结构。我们使用广泛的生物信息学方法计算了 163 种结构特征,并测试了它们对致病性变异的富集情况。我们开发了一种新的 3D 空间距离评分方法,该方法可以比较蛋白质结构中致病性和人群变异的分布。我们发现并独立复制了几个孔残基特性以及与孔轴的接近程度与人群变异相比,对致病性变异的富集最为显著。使用我们的 3D 评分方法,我们表明,在孔内残基和距孔轴中心 5Å 范围内的α螺旋残基中观察到最强的致病性变异富集,而这些残基不参与门控。在位于孔内的残基亚组中,孔的疏水性是与变异致病性最强相关的特征。我们还发现,所鉴定的特性与电压门控钠离子通道(SCN1A、SCN2A、SCN8A)和 N-甲基-D-天冬氨酸受体(GRIN1、GRIN2A、GRIN2B)编码基因的临床表型和体外功能测定之间存在关联。在一个由 1422 种神经发育障碍致病性患者变异和 679 种电生理实验组成的独立专家整理数据集,我们表明,轴距离与癫痫发作年龄和认知表现以及通道功能增益与丧失有关。总之,我们确定了与离子通道功能障碍相关的生物学特性,并表明这些特性与神经发育障碍患者的体外功能测定和临床表型相关。我们的结果表明,预测变异致病性和功能的临床决策支持算法在未来是可行的。